Effects of Obesity on Care and Outcomes in Mechanically Ventilated Individuals in the Intensive Care Unit

Obesity Clinical Trial

Official title:

A Prospective Observational Study of the Association Between Excess Body Weight and Outcome and Process Measures in Mechanically Ventilated Medical Intensive Care Unit Patients

Clinical Trial Details — Status: Terminated

Administrative data

• NCT number: NCT00296088
• Other study ID #: 1330
• Secondary ID: K23HL075076K23HL
• Status: Terminated
• Phase: N/A
• First received: February 23, 2006
• Last updated: July 29, 2013
• Start date: February 2006
• Est. completion date: April 2013

Study information

• Verified date: July 2013
• Source: Ohio State University
• Contact: n/a
• Is FDA regulated: No
• Health authority: United States: Federal Government
• Study type: Observational

Clinical Trial Summary

Obesity is a significant health care issue in the United States, particularly among the critically ill. Preliminary research has shown that differences in ventilator management exist among obese and non-obese individuals. This study will examine the effect of excess weight on ventilator management and clinical outcomes in individuals in an intensive care unit (ICU).

Description:

Sixty-four percent of American adults are overweight or obese. Excess weight will soon surpass smoking as the most common cause of preventable death. Despite the well-known health consequences of obesity, little is known about the specific effects of obesity in critically ill individuals. There are significant differences in ventilator management procedures among obese and non-obese individuals in an ICU. The long-term effect of these differences, however, has not been studied. Preliminary research has shown that differences in the mechanical ventilation process may be responsible for worse outcomes in obese individuals, as compared to non-obese individuals. The purpose of this study is to examine the effect of obesity on ventilator management processes and medical outcomes in individuals in an ICU. The study will also identify any increased risks for the critically ill obese and the causes of their augmented mortality and morbidity levels.

This study will enroll individuals in an ICU who are receiving mechanical ventilation through an endotracheal tube. Because potential participants are critically ill, and are unable to provide consent to participate in the study, each participant must have a surrogate decision maker who will provide consent on their behalf. Once enrolled, participants' weight, height, and waist circumference will be measured. Medical outcomes and information on the processes of ventilator management and care will be assessed while participants are in the ICU. Information on hospital outcomes, quality of life, utility, employment, and living situation will be collected upon release from the ICU, as well as during follow-up telephone interviews, which will occur every 90 days for a period of up to two years.

Recruitment information / eligibility

• Status: Terminated
• Enrollment: 582
• Est. completion date: April 2013
• Est. primary completion date: April 2013
• Accepts healthy volunteers: No
• Gender: Both
• Age group: 18 Years and older

Eligibility

Inclusion Criteria:

• Residing in the ICU at Ohio State University Medical Center (OSUMC)

• Receiving mechanical ventilation through an endotracheal tube

Exclusion Criteria:

• Previously enrolled in this study

• Transferred from another acute care hospital

• Transferred from another ICU at OSUMC more than 24 hours after admission to that ICU

• Prisoner

• Unable to identify a surrogate decision maker or there is a dispute over who is the surrogate decision maker

• Pregnant

• Dies prior to study entry

Study Design

Observational Model: Cohort, Time Perspective: Prospective

Related Conditions & MeSH terms

• Obesity
• Pulmonary Valve Insufficiency
• Respiratory Insufficiency

Locations

Country	Name	City	State
United States	The Ohio State University Medical Center	Columbus	Ohio

Sponsors (2)

Lead Sponsor	Collaborator
Ohio State University	National Heart, Lung, and Blood Institute (NHLBI)

Country where clinical trial is conducted

United States,